TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $1.46M2010: $646.5K2011: $828.5K2012: $1.41M2013: $2.30M2014: $1.37M2015: $2.36M2016: $3.14M2017: $1.35M2018: $4.66M2019: $4.04M2020: $2.50M2021: $1.46M2022: $4.81M2023: $15.29M2024: $10.70M2025: $6.97M$6.97M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$6.97M-34.8%
2024$10.70M-30.1%
2023$15.29M+218.0%
2022$4.81M+230.1%
2021$1.46M-41.8%
2020$2.50M-38.0%
2019$4.04M-13.4%
2018$4.66M+245.4%
2017$1.35M-57.0%
2016$3.14M+32.9%
2015$2.36M+72.5%
2014$1.37M-40.4%
2013$2.30M+62.6%
2012$1.41M+70.5%
2011$828.5K+28.1%
2010$646.5K-55.7%
2009$1.46M—